Vaccines independent medical education

GSK Vaccines: Support for Independent Medical Education

Independent Medical Education (IME) projects eligible for GSK Vaccines’ support via this application process include educational activities in general vaccinology or specific disease areas in which GSK Vaccines has marketed products.

For funding requests targeting a single country, local GSK offices should be contacted.

For US-based organisations requesting grant funding to support IME activities for US-based healthcare professionals, different guidelines apply and this process is not applicable. Please visit for details.

The target recipients of the IME supported by this program should come from a broad international audience.

Recipient programs will develop the knowledge and practice of healthcare professionals in order that they can make the most appropriate curative or preventive treatment decisions for their patients.

GSK-funded IME activities are supported through funding at arm's-length by GSK. This means free from GSK influence on content development and faculty, participant and logistic selection. IME programs developed in this independent way provide a balanced perspective on the subject matter, putting the patient first.  Organisations will be assessed according to defined criteria (below).

Travel Grants: Funding to support the travel and accommodation of attendees to reputable and renowned scientific meetings should be requested through the GSK Vaccines “Support for Travel Sponsorship for global/international IME activities or scientific congresses” request process.

Areas of interest for Independent Medical Education

GSK Vaccines has identified areas of interest where we and others have seen gaps in medical education related to disease areas where GSK has marketed products, as well as in general areas of vaccinology.

These are shared to enable organisations that have the skills, capability and credentials to deliver high-quality medical education to submit requests for funding from GSK to support such programmes.

Criteria for Independent Medical Education

GSK Vaccines will evaluate requests for funding based on essential criteria which include:

  • Assessment of the type of organisation requesting funding (Academic institution that trains healthcare professionals/ medical education charity that educates healthcare professionals/ patient group/ professional medical or scientific association or society/ healthcare service provider that employs healthcare professionals)

  • Evidence of complete independence from any promotional activities related to GSK

  • Absence of Conflicts of Interest in delivering medical education and in receiving funding from GSK

  • Ability to measure Medical Education Desired Results (see Moore DE, et al. J Contin Educ Health Prof. 2009;29:1-15.  Achieving Desired Results and Improved Outcomes: Integrating Planning and Assessment Throughout Learning Activities)

  • Agreement from the recipient programme to be subject to potential independent audit to review quality of education delivered and use of funds provided.

Other local requirements and legislation related to medical education will also be considered.

Contact for Independent Medical Education

Should your organisation wish to seek funding in any of the areas of interest, please contact us using our dedicated mailbox for requests ( managed within Worldwide Vaccinology, Vaccine Education and Medical Training. Details of the process for submissions will be provided following initial contact. 

Timelines for Independent Medical Education Grant Requests

Please note that Grants requests are reviewed quarterly at GSK hence submissions should be made at least 6 months prior to the event for which funding is sought.  Quarterly closure dates for IME grant requests are

  • March 31, 2016 (for events occurring after September 30, 2016)
  • June 30, 2016 (for events occurring after December 31, 2016)
  • September 30, 2016 (for events occurring after March 31, 2017)
  • December 31, 2016 (for events occurring after June 30, 2017)


Areas of Interest for Independent Medical Education


Pediatric pneumococcal diseases prevention

  • The burden of pediatric pneumococcal disease 
  • Efficacy, impact and safety of pneumococcal conjugate vaccines (PCV) 
  • Experience with implementation of pneumococcal conjugate vaccines
  • Cost effectiveness of pneumococcal vaccines


Meningococcal meningitis prevention

  • Burden of Meningococcal meningitis Disease and Prevention


Pertussis Control

  • Burden of Pertussis Disease and Prevention


Measles, mumps, rubella and varicella virus prevention

  • Provide education on how to counsel parents to understand and communicate about the use of MMRV combination vaccine (focus on countries/regions utilizing combination MMRV vaccine e.g. Europe, Canada, Australia, Brazil)
  • The medical burden of varicella disease (e.g. incidence, hospitalisations, complications, Congenital Varicella Syndrome, sequelae)
  • The impact/benefit of vaccinating against varicella (both medical impact and cost effectiveness)


Rotavirus control

  • Rotavirus gastro-enteritis (RVGE) and its contribution to morbidity/mortality in patients worldwide 
  • How to raise awareness and effectively counsel parents on the importance of Rotavirus vaccination for the prevention of RVGE: experience from Health Care Providers daily practices
  • Effectiveness, impact and health economic benefits of Rotavirus vaccination in different socio-economic settings


Influenza (Flu) virus prevention

  • Flu vaccination among specialists taking care of the elderly, health-care workers and children in Europe and Asia 
  • Flu burden of disease and impact of vaccination against different flu strains in Europe and Asia


Human Papilloma Virus (HPV) prevention

  • Cervical Cancer Disease awareness in Asia and Latin America
  • Benefits and risks of Cervical Cancer Prevention through vaccination
  • Effective introduction and maintenance of school based vaccination programs in low-middle income country settings
  • HPV Vaccination of women at cervical cancer screening age


Travel health risks prevention

  • Travel Medicine focused on pre-travel Medical Education for Primary Care Physicians, Nurses and Pharmacists with broad geographical reach including European countries
  • Travel vaccine schedules and potential outcomes of non-adherence to schedules on expected protection with broad geographical reach including European countries
  • Raise awareness of Rabies potential risk for travelers, prevention strategies and their limitations with broad geographical reach including European countries


Rabies prevention

  • Disease burden and prevention in endemic areas with focus on high risk populations


Tick Borne Encephalitis (TBE) prevention

  • Raise awareness of TBE burden and vaccination benefit in at risk populations


Hepatitis B Virus (HBV) prevention

  • Understanding and implementing Hepatitis B vaccination for diabetic patients, chronic liver disease patients & chronic kidney disease patients following local recommendations


General vaccination topics

  • Societal and economic barriers for providers and population to vaccine uptake for all ages (in particular for adolescents, adults and elderly)
  • Innovative solutions for educational activities aiming to increase vaccine awareness and acceptance in all ages
  • Immunosenescence and how it impacts the immune response to vaccines of elderly vs young people
  • The role and value of vaccine solutions beyond the simple cost/benefit assessment of vaccines
  • Impact of communication interventions on vaccination using new digital platforms
  • Immunity of pregnancy and how that relates to vaccination
  • Role of adjuvants in vaccines, how they help antigen(s) in mimicking or improving the activation of immune defense systems
  • Safety of modern vaccines including new technologies: myths and facts
  • Vaccine related education for Internal Medicine and Family Practice Residents
  • Materials to help children and parents understand vaccination